| Literature DB >> 35261018 |
Abir Boussetta, Manel Jellouli, Rym Baati, Tahar Gargah.
Abstract
BACKGROUND: Neurogenic non-neurogenic bladder is a common problem in clinical practice. Untreated, complications can be serious. AIM: Identify complications of neurogenic non-neurogenic bladder and determine the predictive factors of their occurrence.Entities:
Mesh:
Year: 2021 PMID: 35261018 PMCID: PMC9003586
Source DB: PubMed Journal: Tunis Med ISSN: 0041-4131
Table 1 : Distribution of patients in the three groups according to the symptoms of the filling phase
|
|
|
|
| |
|
|
3(12,5) |
3(12,5) |
5 (20,8) |
11(45,8) |
|
|
2(8,3) |
1(4,1) |
2(8,3) |
5(20,8) |
|
|
2(8,3) |
4 (16,7) |
7 (29,1) |
13 (54,1) |
|
|
1(4,1) |
3(12,5) |
7(29,1) |
11 (45,8) |
|
|
0 |
2(8,3) |
1(4,1) |
3(12,5) |
|
|
0 |
0 |
0 |
0 |
|
|
3(12,5) |
2(8,3) |
6 (25) |
9(37,5) |
|
|
1(4,1) |
0 |
0 |
1(4,1) |
|
|
0 |
1(4,1) |
0 |
1(4,1) |
|
|
1(4,1) |
6(25) |
8 (33,3) |
15 (58,3) |
Table 2 : Distribution of patients in the three groups according to the symptoms of the voiding phase
|
|
|
|
| |
|
|
2(8,3) |
2(8,3) |
3(12,5) |
7(29,1) |
|
|
2(8,3) |
3(12,5) |
3(12,5) |
8(25) |
|
|
3(12,5) |
2(8,3) |
2(8,3) |
7(29,1) |
|
|
2(8,3) |
1(4,1) |
4(16,7) |
7(29,1) |
|
|
0 |
2(8,3) |
3(12,5) |
5(20,8) |
Table 3: Distribution of patients in the three groups according to symptoms of the post-voiding phase
|
|
|
|
| |
|
|
1(4,1) |
0(0) |
3(12,5) |
4(16,7) |
|
|
0 |
2(8,3) |
4(16,7) |
6(25) |
Table 4: Urodynamic factors predicting the occurrence of complications in the NNNB
|
|
|
|
|
| |
|
|
|
10 |
9 |
3,42 |
0,07 |
|
|
1 |
1 | |||
|
|
3 |
0 | |||
|
|
|
6 |
9 |
4,2 |
|
|
|
8 |
1 | |||
|
|
|
5 |
10 |
12,24 |
|
|
|
0 |
3 | |||
|
|
6 |
0 | |||
|
|
|
5 |
10 |
11,37 |
|
|
|
8 |
0 | |||
|
|
1 |
0 | |||
|
|
|
4 |
10 |
12,69 |
|
|
|
9 |
0 | |||
|
|
1 |
0 |
p<0.05 : significant